Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry
Author
Abstract
Suggested Citation
DOI: 10.1016/j.irle.2023.106169
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Petra Moser, 2005.
"How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World's Fairs,"
American Economic Review, American Economic Association, vol. 95(4), pages 1214-1236, September.
- Petra Moser, 2003. "How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World Fairs," NBER Working Papers 9909, National Bureau of Economic Research, Inc.
- DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
- Josh Lerner, 2009. "The Empirical Impact of Intellectual Property Rights on Innovation: Puzzles and Clues," American Economic Review, American Economic Association, vol. 99(2), pages 343-348, May.
- Panattoni, Laura E., 2011. "The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms," Journal of Health Economics, Elsevier, vol. 30(1), pages 126-145, January.
- Margaret K. Kyle & Anita M. McGahan, 2012.
"Investments in Pharmaceuticals Before and After TRIPS,"
The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.
- Margaret Kyle & Anita McGahan, 2009. "Investments in Pharmaceuticals Before and After TRIPS," NBER Working Papers 15468, National Bureau of Economic Research, Inc.
- Kyle, Margaret & McGahan, Anita M, 2011. "Investments in Pharmaceuticals Before and After TRIPS," CEPR Discussion Papers 8371, C.E.P.R. Discussion Papers.
- Jorge Lemus & Emil Temnyalov, 2020.
"Pay-for-Delay with Follow-On Products,"
Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 56(4), pages 697-714, June.
- Jorge Lemus & Emil Temnyalov, 2019. "Pay-for-delay with Follow-on Products," Working Paper Series 2019/09, Economics Discipline Group, UTS Business School, University of Technology, Sydney.
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016.
"Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry,"
RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Jin Xie & Joseph Gerakos, 2020. "The Anticompetitive Effects of Common Ownership: The Case of Paragraph IV Generic Entry," AEA Papers and Proceedings, American Economic Association, vol. 110, pages 569-572, May.
- Yi Qian, 2007. "Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002," The Review of Economics and Statistics, MIT Press, vol. 89(3), pages 436-453, August.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Fabian Gaessler & Stefan Wagner, 2022.
"Patents, Data Exclusivity, and the Development of New Drugs,"
The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
- Gaessler, Fabian & Wagner, Stefan, 2019. "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series 176, CRC TRR 190 Rationality and Competition.
- Iftekhar Hasan & Fahad Khalil & Xian Sun, 2017.
"The Impacts of Intellectual Property Rights Protection on Cross-Border M&As,"
Quarterly Journal of Finance (QJF), World Scientific Publishing Co. Pte. Ltd., vol. 7(03), pages 1-35, September.
- Hasan, Iftekhar & Khalil, Fahad & Sun, Xian, 2017. "The impacts of intellectual property rights protection on cross-border M&As," Research Discussion Papers 17/2017, Bank of Finland.
- Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
- Iftekhar Hasan & Fahad Khalil & Xian Sun, 2017.
"The Impacts of Intellectual Property Rights Protection on Cross-Border M&As,"
Quarterly Journal of Finance (QJF), World Scientific Publishing Co. Pte. Ltd., vol. 7(03), pages 1-35, September.
- Hasan, Iftekhar & Khalil, Fahad & Sun, Xian, 2017. "The impacts of intellectual property rights protection on cross-border M&As," Bank of Finland Research Discussion Papers 17/2017, Bank of Finland.
- repec:zbw:bofrdp:2017_017 is not listed on IDEAS
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022.
"Generic competition and the incentives for early-stage pharmaceutical innovation,"
Research Policy, Elsevier, vol. 51(10).
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
- Auriol, Emmanuelle & Biancini, Sara & Paillacar, Rodrigo, 2023.
"Intellectual property rights protection and trade: An empirical analysis,"
World Development, Elsevier, vol. 162(C).
- Emmanuelle AURIOL & Sara BIANCINI & Rodrigo PAILLACAR, 2022. "Intellectual Property Rights Protection and Trade: An Empirical Analysis," Working Paper bf88c1ee-a352-493e-b6bc-d, Agence française de développement.
- Auriol, Emmanuelle & Biancini, Sara & Paillacar, Rodrigo, 2022. "Intellectual Property Rights Protection and Trade: An Empirical Analysis," TSE Working Papers 22-1354, Toulouse School of Economics (TSE).
- Emmanuelle Auriol & Sara Biancini & Rodrigo Paillacar, 2023. "Intellectual property rights protection and trade: an empirical analysis," Post-Print hal-03947266, HAL.
- Heidi L. Williams, 2016.
"Intellectual Property Rights and Innovation: Evidence from Health Care Markets,"
Innovation Policy and the Economy, University of Chicago Press, vol. 16(1), pages 53-87.
- Heidi L. Williams, 2015. "Intellectual Property Rights and Innovation: Evidence from Health Care Markets," NBER Chapters, in: Innovation Policy and the Economy, Volume 16, pages 53-87, National Bureau of Economic Research, Inc.
- Heidi L. Williams, 2015. "Intellectual Property Rights and Innovation: Evidence from Health Care Markets," NBER Working Papers 21246, National Bureau of Economic Research, Inc.
- Malte Mosel, 2009. "Competition, imitation, and R&D productivity in agrowth model with sector-specific patent protection," Working Papers 084, Bavarian Graduate Program in Economics (BGPE).
- Yin, Nina, 2023. "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, vol. 87(C).
- Sarath Balachandran & Exequiel Hernandez, 2019. "Do Institutional Reforms Perpetuate or Mitigate the Matthew Effect? Intellectual Property Rights and Access to International Alliances," Strategy Science, INFORMS, vol. 4(2), pages 151-174, June.
- Pamela J. Smith & Sebastian J. Anti, 2022. "How does TRIPs compliance affect the economic growth of developing countries? Application of the Synthetic Control method," The World Economy, Wiley Blackwell, vol. 45(12), pages 3873-3906, December.
- Yi Qian, 2014. "Counterfeiters: Foes or Friends? How Counterfeits Affect Sales by Product Quality Tier," Management Science, INFORMS, vol. 60(10), pages 2381-2400, October.
- Abdin, Joynal & Sharma, Abhijit & Trivedi, Rohit & Wang, Chengang, 2024. "Financing constraints, intellectual property rights protection and incremental innovation: Evidence from transition economy firms," Technological Forecasting and Social Change, Elsevier, vol. 198(C).
- Nicholas, Tom, 2011. "Cheaper patents," Research Policy, Elsevier, vol. 40(2), pages 325-339, March.
- Gamba, Simona, 2017.
"The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector,"
World Development, Elsevier, vol. 99(C), pages 15-27.
- Simona Gamba, 2016. "The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector," FBK-IRVAPP Working Papers 2016-05, Research Institute for the Evaluation of Public Policies (IRVAPP), Bruno Kessler Foundation.
- Simona Gamba, 2016. "The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector," CESifo Working Paper Series 6004, CESifo.
- Ganguly, Madhuparna, 2021. "Stronger Patent Regime, Innovation and Scientist Mobility," MPRA Paper 107635, University Library of Munich, Germany.
- L. Kamran Bilir, 2014. "Patent Laws, Product Life-Cycle Lengths, and Multinational Activity," American Economic Review, American Economic Association, vol. 104(7), pages 1979-2013, July.
- Ge, Jianjun & Li, Donghui & Ni, Yingzhao & Yang, Shijie, 2022. "Inflexibility and corporate innovation: Cross-country evidence," Journal of Multinational Financial Management, Elsevier, vol. 64(C).
- Milan Miric & Lars Bo Jeppesen, 2020. "Does piracy lead to product abandonment or stimulate new product development?: Evidence from mobile platform‐based developer firms," Strategic Management Journal, Wiley Blackwell, vol. 41(12), pages 2155-2184, December.
- Anton‐Giulio Manganelli, 2021. "Reverse payments, patent strength, and asymmetric information," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 20-35, January.
More about this item
Keywords
Pharmaceutical drugs; Patent protection; Paragraph IV settlement;All these keywords.
JEL classification:
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- K21 - Law and Economics - - Regulation and Business Law - - - Antitrust Law
- L41 - Industrial Organization - - Antitrust Issues and Policies - - - Monopolization; Horizontal Anticompetitive Practices
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:irlaec:v:76:y:2023:i:c:s0144818823000479. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/irle .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.